Malaveeka Chakravarthy
Partner
MumbaiPractice Area
Sectors
It thrills me to advise clients involved in the rapidly growing Indian start-ups sector and other non-traditional businesses.
With over a decade of experience, Malaveeka Chakravarthy has significant experience in representing clients on complex and multi-jurisdictional private equity transactions, joint venture arrangements and strategic acquisitions in the information technology, financial services, manufacturing, and healthcare sectors. She holds an LL.M. from Columbia Law School.
WORK HIGHLIGHTS
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform
-
Advised Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG on its acquisition of a majority stake in Asian Institute of Nephrology and Urology for INR 600 crores
-
On the Indian aspects of its acquisition of GlobalLogic Inc. for USD 9.6 billion
-
On its investment of USD 300 million in Advanta Enterprises Limited, a subsidiary of UPL Limited and a leading global seeds company
-
On its acquisition of the engineering plastics business of Ester Industries Limited for INR 289.23 crore
-
On various investments including in EduTech unicorns such as ‘Byju's’ (part of a USD 500 million round) and ‘Unacademy’ (part of a USD 500 million fund raising round) as well as technology platforms such as ‘OfBusiness’ (part of USD 200 million round)
-
On its acquisition of Famy Life Sciences Private Limited, a market-leading drug development platform